Last Update 07 Mar 26

Fair value Increased 4.67%

NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation.

Analyst Commentary

Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation. Views are not one sided though, and several commentaries highlight risk factors that could matter for valuation and execution over the next few years.

Bullish Takeaways

Bullish analysts see the recent nutrient pricing setup, particularly for nitrogen, as supportive for North American producers and a possible tailwind for Nutrien's earnings power and valuation multiples.
Several reports point to Nutrien's ongoing portfolio actions across Phosphate, Trinidad nitrogen, and Brazil Retail as important levers to improve earnings stability and strengthen free cash flow generation over time.
Some commentary highlights expectations for steady organic Retail growth, improved cost structure, and better cash conversion, which, if delivered, could support higher free cash flow per share and justify higher price targets.
There is also an emphasis on Nutrien's exposure to what is viewed as relatively defensive agricultural commodities, which bullish analysts see as supportive for risk and reward compared with more cyclical chemicals names.

Bearish Takeaways

More cautious analysts flag the risk that current nutrient pricing, particularly in potash, may not be durable over the medium term, especially if supply continues to rise, which could pressure margins and weigh on valuation.
Some commentary references a broader chemicals backdrop with growing oversupply and mixed agricultural conditions, which could limit upside for earnings expectations even if Nutrien executes on internal initiatives.
There is concern that, while there are potential macro and industry catalysts such as rate cuts or capacity rationalization in China, these are still early and too uncertain to underpin a more aggressive upgrade in expectations.
Neutral stances from several firms, despite higher price targets, suggest that execution on cost improvements and portfolio decisions will need to be clear and consistent before more cautious analysts become comfortable with a higher valuation.

What's in the News

The U.S. Department of Justice is investigating whether several commercial fertilizer producers, including Nutrien, Mosaic, CF Industries, Koch and Yara International, coordinated to raise fertilizer prices, according to reporting from Bloomberg based on people familiar with the matter (Bloomberg).
Nutrien announced a normal course issuer bid that would allow the company to repurchase up to 24,057,066 shares, or 5% of its issued share capital, over a 12 month period to March 2, 2027. Any repurchased shares are to be cancelled, and the program is subject to Toronto Stock Exchange acceptance.
From October 1, 2025 to February 17, 2026, Nutrien repurchased 3,638,192 shares for CA$222.28m, bringing total buybacks under the February 19, 2025 program to 11,917,273 shares for CA$681.89m.
Nutrien's Board of Directors declared a quarterly dividend of US$0.55 per share, payable on April 16, 2026 to shareholders of record on March 31, 2026. The company states this is about a 1% increase versus the prior dividend and equates to an annualized US$2.20 per share.
Nutrien issued fiscal 2026 operating guidance, including potash sales volume guidance of 14.1m to 14.8m tonnes, nitrogen sales volume guidance of 9.2m to 9.7m tonnes that assumes no production from the Trinidad and New Madrid facilities, and phosphate sales volume guidance of 2.4m to 2.6m tonnes supported by prior reliability initiatives.

Valuation Changes

Fair Value: The CA$ fair value estimate moved from CA$96.56 to CA$101.07, a modest upward adjustment in the model output.
Discount Rate: The discount rate input edged down from 7.25% to 7.11%, reflecting a slightly lower required return in the updated assumptions.
Revenue Growth: The $ revenue growth assumption in the model shifted from 0.84% to 1.44%, indicating a higher projected top line growth rate within the framework used.
Net Profit Margin: The $ net profit margin assumption increased from 7.35% to 8.12%, pointing to a somewhat higher expected level of profitability in the updated scenario.
Future P/E: The future P/E multiple in the model moved from 20.7x to 19.2x, implying a slightly lower valuation multiple being applied to projected earnings.

40 views

Key Takeaways

Strong global food demand and adoption of advanced agriculture practices are driving steady growth, higher-margin sales, and improved revenue stability for Nutrien.
Operational efficiencies, cost reductions, and disciplined capital allocation are enhancing margins, free cash flow, and shareholder returns over the long term.
Regulatory pressures, shifting agricultural practices, market dependency, execution risks, and lack of diversification threaten Nutrien's profitability, revenue growth, and future market position.

Catalysts

About Nutrien

Provides crop inputs and services.What are the underlying business or industry changes driving this perspective?

Global food demand is structurally supporting long-term fertilizer use: Increasing world population and rising global food demand, particularly in emerging markets, are creating sustained demand for essential crop nutrients like potash and nitrogen-Nutrien's core products-which should underpin stable or growing sales volumes and improve revenue visibility.
Adoption of yield-maximizing and resource-optimizing ag practices: The drive to maximize yields per acre due to climate change, shrinking arable land, and erratic weather is boosting fertilizer adoption and incentivizing precision agriculture. Nutrien's investments in automation, precision ag, and efficiency position it to capture higher-margin, premium sales and expand net margins over time.
Tight industry supply and high operating efficiency: Supply-side constraints, slow addition of new global capacity, and strengthening fertilizer fundamentals have resulted in rising prices and reduced competitive threats, while Nutrien's mine automation and debottlenecking initiatives are lowering per-ton production costs, supporting both top-line growth and margin expansion.
Operational cost reductions and portfolio optimization: Ongoing SG&A and capex reductions, accelerated cost savings programs, and modernization of distribution structures (especially in Brazil and North America) are already increasing adjusted EBITDA and will structurally enhance net margins and free cash flow generation into 2026.
Enhanced shareholder returns and disciplined capital allocation: Consistent share buybacks, durable dividend growth, and asset divestitures are directly increasing free cash flow per share and underpin rising earnings per share, signaling management's confidence in long-term earnings growth and balance sheet strength.

Nutrien Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Nutrien's revenue will grow by 3.2% annually over the next 3 years.
Analysts assume that profit margins will increase from 5.4% today to 8.5% in 3 years time.
Analysts expect earnings to reach $2.3 billion (and earnings per share of $4.87) by about September 2028, up from $1.4 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $1.6 billion.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.2x on those 2028 earnings, down from 20.3x today. This future PE is greater than the current PE for the US Chemicals industry at 11.3x.
Analysts expect the number of shares outstanding to decline by 1.53% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.22%, as per the Simply Wall St company report.

Nutrien Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Increasing regulatory scrutiny and potential tightening of environmental regulations on fertilizer production, especially around greenhouse gas emissions and water usage, could drive higher compliance and operational costs, negatively impacting Nutrien's net margins over the long term.
Advances in regenerative agriculture, organic farming practices, and precision agriculture technologies may reduce reliance on synthetic fertilizers, leading to decreased fertilizer application rates and a potential shrinkage of Nutrien's long-term addressable market, pressuring revenue growth.
Nutrien remains highly dependent on potash and nitrogen products for the majority of its earnings; if global fertilizer prices weaken or if alternative crop nutrition solutions such as biologicals and enhanced efficiency fertilizers gain widespread adoption, Nutrien could experience significant revenue and earnings volatility.
The company's success in cost reduction and margin improvement initiatives in key markets like Brazil is contingent on favorable market conditions; any setbacks in execution or sustained market headwinds could undermine improvements in free cash flow and net margins.
Ongoing consolidation and competitive pressures in the fertilizer and crop input sector may erode Nutrien's pricing power, and failure to sufficiently diversify its product portfolio or geographic exposure-especially outside of North America-could result in stagnant or declining revenue and market share over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of CA$86.165 for Nutrien based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CA$96.39, and the most bearish reporting a price target of just CA$61.11.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $27.5 billion, earnings will come to $2.3 billion, and it would be trading on a PE ratio of 15.2x, assuming you use a discount rate of 7.2%.
Given the current share price of CA$78.39, the analyst price target of CA$86.17 is 9.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Nutrien?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty